14th – 17th June, London
Richmond Pharmacology in conjunction with IIR Life Sciences
The 6th Annual Phase I Clinical Trials Conference is the only industry-focused European meeting dealing with regulatory, operational and technological developments in the international Phase I environment.
As well as an essential applied regulatory update, the meeting will showcase novel technologies for expediting Phase I trials and explore related areas, including cardiovascular safety assessment, imaging and biomarkers.
As part of the conference, Dr Jörg Täubel will explore the new paradigm of Phase I Patient Studies.
“Early Phase Trials Integration – redefining the boundaries”
The speaker will explore an integrated approach to clinical trials and the advantages of the recently implemented EU Clinical Trials Directive by reaching patient groups from the onset of a compound's clinical development.
The presentation will consider crucial elements required to deliver a Phase I patient study, including in-patient facilities and access to consultants, patient populations, and specialist services such as biomarker analysis, proteomics and genomics, providing a one centre solution to early phase studies.
Day 2: 15th June 2005, 10:20am, Stream B
For more information on attending the event as guests of Richmond and receiving a 25% discount on the ticket price, please contact Charlotte Gowling on 020 8879 7111 or email c.gowling@richmondpharmacology.com.
London Hilton Paddington
146 Praed Street
London
W2 1EE
Tel:
+44 (0) 20 7850 0500
Fax:
+44 (0) 20 7850 0500